Ignite Creation Date:
2025-12-25 @ 12:43 AM
Ignite Modification Date:
2025-12-25 @ 10:55 PM
Study NCT ID:
NCT04074967
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-11-06
First Post:
2019-08-19
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study of ARRY-614 Plus Either Nivolumab or Nivolumab+Ipilimumab
Sponsor:
Dan Zandberg
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-06-11
Start Date Type:
ACTUAL
Primary Completion Date:
2024-12-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2019-08-19
First Submit QC Date:
None
Study First Post Date:
2019-08-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-04
Last Update Post Date:
2025-11-06
Last Update Post Date Type:
ESTIMATED